Comparison
Newer thrombin inhibitors vs Heparin
Design
Review
Authors
Loading...
Cautious adoption only where heparin is limited; leaves open dedicated RCTs for thrombotic disorders.
Novel thrombin inhibitors may overcome certain limitations of heparin in the management of thrombotic disorders.
Weitz et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: